ONSURA
Mark Identification

ONSURA

Serial Number

87641241

Filing Date

Oct 11, 2017

Trademark by

TEVA PHARMACEUTICALS USA INC.

Classification Information

Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, pharmaceutical agents affecting the central nervous system; pharmaceutical preparations, namely, pharmaceutical agents affecting circulatory systems; pharmaceutical preparations, namely, pharmaceutical agents affecting sensory organs; pharmaceutical preparations, namely, pharmaceutical agents affecting urogenital organs; pharmaceutical preparations, namely, pharmaceutical agents affecting peripheral nervous system

Pharmaceuticals